Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

HPE 101

Known as: HPE-101 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We evaluated a needle-free injector (NFI), which has been studied as an administration device to the subcutaneous tissue, as a… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2007
2007
Phenserine (PS) was designed as a selective acetylcholinesterase (AChE) inhibitor, with a tartrate form (PST) for oral… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2006
2006
The influence of skin permeation enhancers, such as dimethyl sulphoxide (DMSO) and 1-[2-(decylthio)ethyl]azacyclopentan-2-one… 
  • figure 1
2004
2004
Microdialysis was applied to determine the in vivo transdermal absorption of methotrexate (MTX) in rats with or without a new… 
1996
1996
The purpose of this study was to evaluate the effect of absorption enhancer on in‐vivo transdermal absorption of cyclosporin… 
1994
1994
The suitability of sampling via microdialysis for a lipophilic drug, valproate (VPA), was evaluated by the elimination rate… 
1993
1993
Abstract— The penetration enhancer, 1‐[2‐(decylthio)ethyl]azacyclopentan‐2‐one (HPE‐101), significantly enhanced the excretion of… 
1992
1992
A new compound, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) was synthesized, and its skin penetration enhancing activity… 
1992
1992
Prostaglandin E1 (PGE1) and its inclusion complexes with beta-cyclodextrin (beta-CyD) and O-carboxymethyl-O-ethyl-beta… 
1992
1992
Abstract— The optimal prescription of transdermal preparations of prostaglandin E1 (PGE1) for treatment of peripheral vascular…